Univest
Univest
  • Markets

Rainbow Children’s Medicare Share Price Falls 1.15% After Q1 Results

  • July 31, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Rainbow Children's Medicare Share Price Falls 1.15% After Q1 Results

Rainbow Children’s Medicare falls 1.15% to Rs 1,503.10. Q1 FY27 PAT Rs 60.6 crore vs Rs 53.5 crore (+13.2% YoY). Revenue Rs 470 crore vs Rs 352.8 crore approx (+33.2% YoY).

The Rainbow Children’s Medicare share price fall after Q1 results theme was in focus on Friday, with Rainbow Children’s Medicare shares moving 1.15% to Rs 1,503.10, from a previous close of Rs 1,520.60, after the company reported its results for the quarter ended June 2026.

Rainbow Children’s Medicare reported a profit after tax of Rs 60.6 crore for Q1 FY27, against Rs 53.5 crore in the year-ago quarter, a change of +13.2%. Revenue for the quarter stood at Rs 470 crore, compared with Rs 352.8 crore approx a year earlier, a change of +33.2%.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Rainbow Children’s Medicare Q1 FY27 Results: Key Numbers
  • Why Rainbow Children’s Medicare Shares Moved 1.15% Today
  • About Rainbow Children’s Medicare
  • What to Watch Going Forward
  • Conclusion
  • Frequently Asked Questions on Rainbow children’s medicare share price fall after q1 results
    • Why did Rainbow Children’s Medicare share price fall after Q1 results?
    • What was Rainbow Children’s Medicare’s profit in Q1 FY27?
    • What was Rainbow Children’s Medicare’s revenue in Q1 FY27?
    • What is Rainbow Children’s Medicare’s current share price?
    • Should I buy Rainbow Children’s Medicare shares after the Q1 results move?
    • Where can I track Rainbow Children’s Medicare’s live share price?

Rainbow Children’s Medicare Q1 FY27 Results: Key Numbers

Metric Q1 FY27 Q1 FY26 YoY Change
Profit After Tax Rs 60.6 crore Rs 53.5 crore +13.2%
Revenue Rs 470 crore Rs 352.8 crore approx +33.2%

Why Rainbow Children’s Medicare Shares Moved 1.15% Today

Check the Univest Screener for sector-linked stocks

Strong revenue growth from hospital network expansion in Maharashtra and Andhra Pradesh supported the profit increase.

About Rainbow Children’s Medicare

Multi-specialty paediatric, obstetrics and gynaecology hospital chain across South and West India.

Download the Univest iOS App or Univest Android App to track Rainbow Children’s Medicare’s stock price and quarterly results.

What to Watch Going Forward

Investors tracking Rainbow Children’s Medicare should watch management commentary on demand trends, cost pressures and full-year guidance in the coming quarters, since forward-looking statements often matter as much as the headline quarterly numbers for how the stock trades over the following weeks.

Conclusion

The Rainbow Children’s Medicare share price fall after Q1 results move reflects the market’s reaction to the company’s latest quarterly performance. Investors should evaluate the stock against its own growth trajectory and valuation, and consult a SEBI-registered financial advisor before making any investment decision.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Rainbow Children’s Medicare share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Rainbow children’s medicare share price fall after q1 results

Why did Rainbow Children’s Medicare share price fall after Q1 results?

Ans. Rainbow Children’s Medicare shares moved 1.15% after the company reported Q1 FY27 profit after tax of Rs 60.6 crore, a change of +13.2% from Rs 53.5 crore a year earlier, on revenue of Rs 470 crore.

What was Rainbow Children’s Medicare’s profit in Q1 FY27?

Ans. Rainbow Children’s Medicare reported a profit after tax of Rs 60.6 crore for the quarter ended June 2026, compared with Rs 53.5 crore in the same quarter a year earlier.

What was Rainbow Children’s Medicare’s revenue in Q1 FY27?

Ans. Rainbow Children’s Medicare’s revenue for Q1 FY27 stood at Rs 470 crore, compared with Rs 352.8 crore approx a year earlier, a change of +33.2%.

What is Rainbow Children’s Medicare’s current share price?

Ans. Rainbow Children’s Medicare shares were trading at Rs 1,503.10 today, falling 1.15% from the previous close of Rs 1,520.60.

Should I buy Rainbow Children’s Medicare shares after the Q1 results move?

Ans. Investment decisions should be based on individual research and risk appetite; consult a SEBI-registered financial advisor before buying or selling shares after any results-driven move.

Where can I track Rainbow Children’s Medicare’s live share price?

Ans. Rainbow Children’s Medicare’s live share price and quarterly result updates can be tracked on the Univest platform alongside SEBI-registered research.



After Q1 Results
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply